
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
The Best States to Practice
Physicians Practice
The Great American Physician Survey
Physicians Practice
Salary Calculator
Meetings
Company Salaries and Reviews
Salary Report




